CoChat

Bioavailability of Oral Hydrocortisone Corrected for Binding Proteins and Measured by LC-MS/MS Using Serum Cortisol and Salivary Cortisone

Open access
TN, Johnson, MJ, Whitaker, B, Keevil, RJ, Ross · 2018 · Journal of Bioequivalence & Bioavailability

The DOI matches its Crossref record; 13 of the 14 references it cites were found in a registry or an index; 12 of the 26 sources its claims cite were checked for support.

Abstract

CONTEXT: The assessment absolute bioavailability of oral hydrocortisone is complicated by its saturable binding to cortisol binding globulin (CBG). Previous assessment of bioavailability used a cortisol radioimmunoassay which has cross reactivity with other steroids. Salivary cortisone is a measure of free cortisol and LC-MS/MS is the gold standard method for measuring steroids. We here report the absolute bioavailability of hydrocortisone calculated using serum cortisol and salivary cortisone measured by LC-MS/MS. METHODS: 14 healthy male dexamethasone suppressed volunteers were administered 20 mg hydrocortisone either intravenously or orally by tablet. Samples of serum and saliva were taken and measured for cortisol and cortisone by LC-MS/MS. Serum cortisol was corrected for saturable binding using published data and pharmacokinetic parameters derived using the program WinNonlin. RESULTS: The mean (95% CI) bioavailability of oral hydrocortisone calculated from serum cortisol, unbound serum cortisol and salivary cortisone was 1.00 (0.89-1.14); 0.88 (0.75-1.05); and 0.93 (0.83-1.05), respectively. CONCLUSION: The data confirm that, after oral administration, hydrocortisone is completely absorbed. The data derived from serum cortisol corrected for protein binding, and that from salivary cortisone, are similar supporting the concept that salivary cortisone reflects serum free cortisol levels and that salivary cortisone can be used as a non-invasive method for measuring the pharmacokinetics of hydrocortisone.

Overview

CoChat Summary

TL;DR

In 14 healthy dexamethasone-suppressed men, oral hydrocortisone 20 mg was completely absorbed; absolute bioavailability by LC-MS/MS was 1.00 from total serum cortisol, 0.88 from calculated unbound serum cortisol, and 0.93 from salivary cortisone. Salivary cortisone tracked free cortisol and may offer a non-invasive pharmacokinetic measure.

Key findings

  • Mean (95% CI) absolute bioavailability of oral hydrocortisone was 1.00 (0.89–1.14) from total serum cortisol, 0.88 (0.75–1.05) from calculated unbound serum cortisol, and 0.93 (0.83–1.05) from salivary cortisone; these were not statistically different.
  • AUC0-inf variability was highest for calculated unbound serum cortisol (46% IV, 50% oral) and lowest for salivary cortisone (22% IV, 20% oral); similar patterns were seen for Cmax.
  • After 20 mg oral hydrocortisone, total plasma AUC was 1009 ± 383 ng/ml*h, Cmax 319 ± 109 ng/ml, and median Tmax 1.125 h (0.5–1.5 h), similar to prior Derendorf et al. values.
  • Salivary cortisone Cmax occurred at the same time as serum cortisol Cmax, supporting salivary cortisone as a surrogate for unbound serum cortisol.

Methods

  • Fourteen healthy male subjects with median (IQR) age 28 (25–36) years, weight 83 (75–90) kg, and BMI 25.3 (23.1–26.3) kg/m² received 20 mg oral hydrocortisone and 20 mg IV hydrocortisone at 07:00 h in random order, with dexamethasone suppression.
  • Serum cortisol and salivary cortisol/cortisone were measured by LC-MS/MS; serum cortisol was corrected for saturable binding using published data to estimate unbound serum cortisol.
  • PK endpoints Cmax, AUC0-inf, and Tmax were derived by non-compartmental analysis in WinNonlin Phoenix; bioavailability was calculated from IV and oral AUC0-inf using log-transformed data and a fixed-effects general linear model accounting for sequence and treatment.

Limitations

  • Stated: unbound cortisol was calculated from a literature-derived model rather than measured individually, which may have contributed to higher variability.
  • Stated: the 2 × 2 study design may limit detection of intra-individual variability and possible carryover effects.
  • Evident: the sample was small and included only healthy male volunteers, so findings may not directly generalize to children or patients with adrenal insufficiency, although the paper suggests clinical value in monitoring children.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.4172/jbb.1000365

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Pharmacokinetic figures for: A. Total serum cortisol; B. Calculated unbound serum cortisol; C. Salivary cortisone following oral or IV administration of 20 mg hydrocortisone.
Figure 1 Pharmacokinetic figures for: A. Total serum cortisol; B. Calculated unbound serum cortisol; C. Salivary cortisone following oral or IV administration of 20 mg hydrocortisone.CC BY · PubMed Central

Verification

Claims the paper makes

9 Valid · 1 Not valid · 14 Not checked · 22 Own results and interpretations

22 more claims · 1 with their cited sources checked

Create a free account to see all 46 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 13
  • Probably not a substantial claim. 9

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 13 references

Cited by

See all 12

Metadata

Authors
TN, J., MJ, W., B, K., & RJ, R.
Affiliations
  • University of Sheffield (GB)
  • Manchester Academic Health Science Centre (GB)
Corresponding author
RJ, Ross
Venue
Journal of Bioequivalence & Bioavailability
Published
2018
Volume
10
Issue
1
Pages
001-3
ISSN
0975-0851 (ISSN-L)
OpenAlex
W2776319375
Cited by
12
References
14
Citations by year
2025: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 1
FWCI
1.39
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Bioequivalence & Bioavailability (publishedVersion)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion, cc-by)
  • PubMed Central (acceptedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
cortisol, absolute bioavailability, oral bioavailability, corticosteroid-binding globulin, salivary cortisone, free cortisol, serum cortisol, pharmacokinetics, dexamethasone suppression, non-invasive biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.